Risk of Tuberculosis During Infliximab Therapy for Inflammatory Bowel Disease, Rheumatoid Arthritis, and Spondyloarthropathy: A Meta-Analysis

Experimental and Therapeutic Medicine - Greece
doi 10.3892/etm.2016.3548
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications


Related search